Quantitative immunohistochemical analysis of islet amyloid polypeptide (IAPP) in normal, impaired glucose tolerant, and diabetic cats

Amyloid

Volumn 5, Issue 4, 1998, Pages 255-261

  Ma, Zhi ^a   Westermark, Gunilla T ^a   Johnson, Kenneth H ^b   O'Brien, Timothy D ^b   Westermark, Per ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Amyloidosis; Cat; Immunohistochemistry; Impaired glucose tolerance; Islet amyloid polypeptide; Non insulin dependent diabetes mellitus

Indexed keywords

AMYLIN; AMYLOID;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; COMPARATIVE STUDY; DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; IMMUNOHISTOCHEMISTRY; METABOLISM;

AMYLOID; ANIMALS; CAT DISEASES; CATS; DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; IMMUNOHISTOCHEMISTRY;

EID: 0032243186     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506129809007298     Document Type: Article

References (36)

1. Westermark P, Wernstedt C, O'Brien TD, Hayden DW and Johnson KH (1987). Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Path 127, 414-417
2. Westermark P and Wilander E (1978). The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia 15, 417-421
3. Cooper GJS, Day AJ, Willis AC, Roberts AN, Reid KBM and Leighton B (1989) Amylin and the amylin gene: structure, function and relationship to islet amyloid and to diabetes mellitus. Biochim Biophys Acta 1014, 247-258
4. Johnson KH, O'Brien TD, Jordan KH, Betsholtz C and Westermark P (1990). The putative hormone islet amyloid polypeptide (IAPP) induces impaired glucose tolerance in cats. Biochem Biophys Res Commun 167, 507-513
5. Westermark P (1996). Islet pathology of non-insulin-dependent diabetes mellitus (NIDDM). Diabetic Medicine 13, S46-S48
6. Betsholtz C, Svensson V, Rorsman F, Engström U, Westermark GT, Wilander E, Johnson KH and Westermark P (1989). Islet amyloid polypeptide (IAPP): cDNA cloning and identification of an amyloidogenic region associated with species-specific occurrence of age-related diabetes mellitus. Exp Cell Res 183, 484-493
7. Betsholtz C, Christmanson L, Engström U, Rorsman F, Jordan K, O'Brien TD, Murtaugh M, Johhhnson KH and Westermark P (1990). Structure of cat islet amyloid polypeptide and identification of amino acid residues of potential significance for islet amyloid formation. Diabetes 39, 118-122
8. Westermark P, Engström U, Johnson KH, Westermark GT and Betsholtz C (1990). Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci USA 87, 5036-5040
9. Johnson KH, O'Brien TD, Jordan K and Westermark P (1989). Impaired glucose tolerance is associated with increased islet amyloid polypeptide (IAPP) immunoreactivity in pancreatic beta cells. Am J Path 135, 245-250
10. Steiner DF, Ohagi S, Nagamatsu S, Bell GI and Nishi M (1991). Is islet amyloid polypeptide a significant factor in pathogenesis or pathophysiology of diabetes? Diabetes 40, 305-309
11. Westermark P, Li ZC, Westermark GT, Leckström A and Steiner DF (1996). Effects of beta cell granule components on human islet amyloid polypeptide fibril formation. FEBS Lett 379, 203-206
12. Höppener JWM, Verbeek JS, de Koning EJP, Oosterwijk C, van Hulst KL, Visser-Vernooy HJ, Hofhuis FMA, van Gaalen S, Berends MJH, Hackeng WHL, Jansz HS, Morris JF, Clark A, Capel PJA and Lips CJM (1993). Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia. Diabetologia 36, 1258-1265
13. de Koning EPJ, Morris ER, Hofhuis FMA, Posthuma G, Höppener JWM, Morris JF, Capel PJA, Clark A and Verbeek JS (1994). Intra- and extracellular amyloid fibrils are formed in cultured pancreatic islets of transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci USA 91, 8467-8471
14. Westermark GT, Benig Arora M, Fox N, Carroll R, Chan SJ, Westermark P and Steiner DF (1995). Amyloid formation in response to β cell stress occurs in vitro, but not in vivo, in islets of transgenic mice expressing human islet amyloid polypeptide. Mol Med 1, 542-553
15. Verchere CB, D'Alessio DA, Palmiter RD, Weir GC, Bonner-Weir S, Baskin DG and Kahn SE (1996). Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc Natl Acad Sci USA 93, 3492-3496
16. vy/a mice expressing human islet amyloid polypeptide. Diabetes 47, 743-750
17. Johnson KH, Hayden DW, O'Brien TD and Westermark P (1986). Spontaneous diabetes-islet amyloid complex in adult cats. Am J Path 125, 416-419
18. Yano BL, Hayden DW and Johnson KH (1981). Feline insular amyloid: association with diabetes mellitus. Vet Pathol 18, 621-627
19. Lutz TA and Rand JS (1995). Pathogenesis of feline diabetes mellitus. Vet Clin North Am Small Anim Pract 25, 527-552
20. Ma Z, Westermark GT, Li ZC, Engström U and Westermark P (1997). Altered immunoreactivity of islet amyloid polypeptide (IAPP) may reflect major modifications of the IAPP molecule in amyloidogenesis. Diabetologia 40, 793-801
21. O'Brien TD, Hayden DW, Johnson KH and Stevens JB (1985). High dose intravenous glucose tolerance test and serum insulin and glucagon levels in diabetic and non-diabetic cats: relationships to insular amyloidosis. Vet Path 22, 250-261
22. Christmanson L, Betsholtz C, Leckström A, Engström U, Cortie C, Johnson KH, Adrian TE and Westermark P (1993). Islet amyloid polypeptide in the rabbit and European hare: studies on its relationship to amyloidogenesis. Diabetologia 36, 183-188
23. Hsu SM, Raine L and Fanger H (1981). Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29, 577-580
24. Puchtler H, Sweat F and Levine M (1962). On the binding of Congo red by amyloid. J Histochem Cytochem 10, 355-364
25. Westermark P, Wilander E, Westermark GT and Johnson KH (1987). Islet amyloid polypeptide-like immunoreactivity in the islet B cells of Type 2 (non-insulin-dependent) diabetic and nondiabetic individuals. Diabetologia 30, 887-892
26. Narita R, Toshimori H, Nakazato M, Kuribayashi T, Toshimori T, Kawabata K, Takahashi K and Masukura S (1992). Islet amyloid polypeptide (IAPP) and pancreatic islet amyloid deposition in diabetic and non-diabetic patients. Diab Res Clin Pract 15, 3-14
27. Westermark GT, Christmanson L, Terenghi G, Permerth J, Betsholtz C, Larsson J, Polak JM and Westermark P (1993). Islet amyloid polypeptide: demonstration of mRNA in human pancreatic islets by in situ hybridization in islets with and without amyloid deposits. Diabetologia 36, 323-328
28. Clark A, Wells CA, Buley ID, Cruickshank JK, Vanhegan RI, Matthews DR, Cooper GJS, Holman RR and Turner RC (1988). Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diab Res 9, 151-159
29. O'Brien TD, Hayden DW, Johnson KH and Fletcher TF (1986). Immunohistochemical morphometry of pancreatic endocrine cells in diabetic, normoglycaemic glucose-intolerant and normal cats. J Comp Path 96, 357-369
30. Sanke T, Hanabusa T, Nakano Y, Oki C, Okai K, Nishimura S, Kondo M and Nanjo K (1991). Plasma islet amyloid polypeptide (amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 34, 129-132
31. Ludvik B, Lell B, Hartter E, Schnack C and Prager R (1991). Decrease of stimulated amylin release precedes impairment of insulin secretion in type-II diabetes. Diabetes 40, 1615-1619
32. Kautzky-Willer A, Thomaseth K, Ludvik B, Nowotny P, Rabensteiner D, Waldhäusl W, Pacini G and Prager R (1997). Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes. Diabetes 46, 607-614
33. Howard CF and van Bueren A (1986). Changes in islet cell composition during development of diabetes in Macaca nigra. Diabetes 35, 165-171
34. de Koning EJP, Bodkin NL, Hansen BC and Clark A (1993). Diabetes mellitus in Macaca mulatta monkeys is characterized by islet amyloidosis and reduction in beta-cell population. Diabetologia 36, 378-384
35. Ashburn TT and Lansbury PT (1993). Interspecies sequence variations affect the kinetics and thermodynamics of amyloid formation: peptide models of pancreatic amyloid. J Am Chem Soc 115, 11012-11013
36. Chargé SBP, de Koning EJP and Clark A (1995). Effects of pH and insulin on fibrillogenesis of islet amyloid polypeptide in vitro. Biochemistry 34, 14588-14593